Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Demers

Showing results (11-20 of 433) with videos related to

Pageof 44
Sort By:
Clinical Chemistry|July 1, 1979
Free thyroxine assay and thyroxine index comparedL M Demers
La Ricerca in Clinica E in Laboratorio|January 1, 1979
Serum bile acids (a new advance in the diagnosis of liver disease)L M Demers
Breast Cancer Research and Treatment|January 1, 1994
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patientsL M Demers
Expert Opinion on Pharmacotherapy|February 4, 2003
Andropause: an androgen deficiency state in the ageing maleLaurence M Demers
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1997
Clinical usefulness of markers of bone degradation and formationL M Demers
Clinics in Laboratory Medicine|May 26, 2004
Thyroid disease: pathophysiology and diagnosisLaurence M Demers
Quality Management in Health Care|February 2, 1994
Tutorial: implementing hoshin planning at the Vermont Academic Medical CenterD M Demers
Clinical Chemistry|November 1, 1992
New biochemical marker for bone disease: is it a breakthrough?L M Demers
Clinical Chemistry|March 1, 1991
Monoclonal antibodies to lutropin: are our immunoassays too specific?L M Demers
Clinical Chemistry|August 3, 1999
Biochemical markers in the management of patients with metastatic bone diseaseL M Demers
Pageof 44

Showing results (11-20 of 433) with videos related to

Sort By:
Pageof 44
Clinical Chemistry|July 1, 1979
Free thyroxine assay and thyroxine index comparedL M Demers
La Ricerca in Clinica E in Laboratorio|January 1, 1979
Serum bile acids (a new advance in the diagnosis of liver disease)L M Demers
Breast Cancer Research and Treatment|January 1, 1994
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patientsL M Demers
Expert Opinion on Pharmacotherapy|February 4, 2003
Andropause: an androgen deficiency state in the ageing maleLaurence M Demers
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1997
Clinical usefulness of markers of bone degradation and formationL M Demers
Clinics in Laboratory Medicine|May 26, 2004
Thyroid disease: pathophysiology and diagnosisLaurence M Demers
Quality Management in Health Care|February 2, 1994
Tutorial: implementing hoshin planning at the Vermont Academic Medical CenterD M Demers
Clinical Chemistry|November 1, 1992
New biochemical marker for bone disease: is it a breakthrough?L M Demers
Clinical Chemistry|March 1, 1991
Monoclonal antibodies to lutropin: are our immunoassays too specific?L M Demers
Clinical Chemistry|August 3, 1999
Biochemical markers in the management of patients with metastatic bone diseaseL M Demers
Pageof 44